SCHEMBL5833675

SCHEMBL5833675

C[C@H](O)C(=O)N1CC=C(c2c(F)cc(N3CC(C(N)c4ccon4)OC3=O)cc2F)CC1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.36
MAOA P21397 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5834336 0.91 MET (0.31) BTK
SCHEMBL5833671 0.81 MAOA (0.51) BTKMAOA
SCHEMBL6765855 0.77 TRPV1 (0.30) BTKMAOA
SCHEMBL5833681 0.75 BTK (0.36) BTK
SCHEMBL12665398 0.75 GRM2 (0.35) MAOA
SCHEMBL7081127 0.74 MAOA (0.34) MAOA
SCHEMBL7081128 0.74 MAOA (0.34) MAOA
SCHEMBL5834330 0.74 MAOA (0.48) MAOA
Posizolid SCHEMBL374786 0.73 MAOA (0.34) BTKMAOA
Posizolid SCHEMBL7079325 0.73 MAOA (0.34) BTKMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087629-B2 Useful activity against Gram-positive pathogens and, in particular, against various strains exhibiting resistance to vancomycin and against E. faecium strains resistant to both aminoglycosides and clinically used beta-lactams ASTRAZENECA AB (SE) 2006-08-08 US disclosed
US-6734200-B1 ANTIBIOTIC COMPOUNDS CONTAINING A SUBSTITUTED OXAZOLIDINONE RING; ACTIVITY AGAINST GRAM-POSITIVE PATHOGENS ASTRAZENECA AB (SE) 2004-05-11 US disclosed